DRUGMAKERS WILL ASK US GOVERNMENT TO PAUSE DRUG PRICE NEGOTIATIONS
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli Lilly's CEO David Ricks. Ricks said at the JPMorgan Healthcare Conference that the government needs to "fix" the Inflation Reduction Act (IRA) before the second round of talks over price cuts, the report added. Under the IRA, President Joe Biden's signature legislation, prices for 10 highly popular prescription drugs used by Medicare will be cut by 38% to 79% in 2026. Regulators are due to announce the list of 15 more drugs by February.
A healthcare whistleblower and the author of the bestselling book "Moving Beyond the Covid-19 Lies: Restoring Health and Hope for Humanity". In the book he exposes the dirty secrets about our healthcare system. DR. BRYAN ARDIS
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.